Pharnext
Records under this name other than the patents Pharnext holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,393,241 | Compositions for treating CMT and related disorders Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,427,436 | Compositions for treating CMT and related disorders Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,566,275 | Compositions for treating CMT and related disorders Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,583,135 | Compositions for treating CMT and related disorders Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,992,891 | Therapeutic approaches for treating CMT and related disorders Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,300,015 | Stable oral solutions for combined API Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,383,870 | Early treatment of CMT disease Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,045,971 | Compositions for Treating Amyotrophic Lateral Sclerosis Lapsed on the fee record Ended Aug 14, 2026 · High confidence | Lapsed on the fee record | Ended Aug 14, 2026 | High confidence |
| US 8,741,886 | Baclofen and acamprosate based therapy of neurological disorders Lapsed on the fee record Ended Jun 3, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 3, 2026 | From the USPTO record |
| US 9,945,876 | Diagnostic tools for charcot-marie-tooth disease Lapsed on the fee record Ended Apr 17, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2026 | From the USPTO record |